Is this tech company behind CEO's bid for 23andMe genetic data? How Anne Wojcicki's group still could snag 23andMe How Anne ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...

Former CEO to fight 23andMe deal © 2025 American City Business Journals. All rights reserved. Use of and/or registration on ...

The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...

Regeneron is buying bankrupt genetic testing firm 23andMe, which helped usher in the era of consumer DNA test kits nearly two ...

Me has found a buyer in biotech company Regeneron Pharmaceuticals. If you want your data removed, here are your options.

Me, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale.

How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in ...

Me has faced an uncertain future after struggles to find a profitable business model and privacy concerns related to ...